28PImpact of the 21-gene assay on treatment decisions in high-risk patients with ER-positive HER2-negative early breast cancer: Results of the KARMA Dx study. (13th May 2019) - Llombart, A; Andrés, R; Anton Torres, A; Martinez, N; Rodriguez, C; Sánchez-Rovira, P; Rojas, B; Ruiz Borrego, M; Bermejo, B; Martinez de Dueñas, E